Is Equasens SA a good investment? Equasens SA (EQS.PA) is currently trading at 30.95 EUR. Market analysts have a consensus price target of 54.68 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 12.07. This relatively low multiple may signal that Equasens SA is undervalued compared to historical market norms.
Earnings Schedule: Equasens SA is expected to release its next earnings report on Sept. 28, 2026. The market consensus estimate for Forward EPS is 3.29.
For income investors, Equasens SA pays a dividend yield of 4.55%. With a payout ratio of 26%, the dividend appears sustainable.
Yes, it pays an annual dividend of 1.40 EUR (4.55% yield).
Equasens SA is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Sept. 28, 2026. The company currently has a trailing EPS of 2.59.
Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; after-sales services, and telephone support and maintenance; and data backup, intermediation, and vocational training services. It also provides medical remote monitoring systems, develops a structured medical speech recognition solution, and designs and manufactures connected electronic devices and equipment, as well as offers interoperability solutions. In addition, the company offers financing platform to facilitate multi-donor management, and financing solutions for leased assets for healthcare professionals and others. It serves healthcare facilities and healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.52 EUR
|
| July 5, 2027 (estimated) | 1.5201 |
| ▸2026 |
1.40 EUR
|
| July 3, 2026 | 1.4000 |
| ▸2025 |
1.25 EUR
|
| July 4, 2025 | 1.2500 |
| ▸2024 |
1.25 EUR
|
| July 4, 2024 | 1.2500 |
| ▸2023 |
1.15 EUR
|
| July 5, 2023 | 1.1500 |
| ▸2022 |
1.05 EUR
|
| July 4, 2022 | 1.0500 |
| ▸2021 |
0.95 EUR
|
| July 5, 2021 | 0.9500 |
| ▸2020 |
0.90 EUR
|
| July 3, 2020 | 0.9000 |
| ▸2019 |
0.85 EUR
|
| July 3, 2019 | 0.8500 |
| ▸2018 |
0.75 EUR
|
| July 4, 2018 | 0.7500 |
| ▸2017 |
0.65 EUR
|
| July 3, 2017 | 0.6500 |
| ▸2016 |
0.60 EUR
|
| June 30, 2016 | 0.6000 |
| ▸2015 |
3.48 EUR
|
| July 1, 2015 | 2.9000 |
| June 30, 2015 | 0.5800 |
| ▸2014 |
3.00 EUR
|
| July 1, 2014 | 2.5000 |
| June 30, 2014 | 0.5000 |
| ▸2013 |
2.10 EUR
|
| June 25, 2013 | 2.1000 |
| ▸2012 |
1.80 EUR
|
| July 4, 2012 | 1.8000 |
| ▸2011 |
1.50 EUR
|
| Aug. 29, 2011 | 1.5000 |
| ▸2010 |
1.40 EUR
|
| Aug. 27, 2010 | 1.4000 |
| ▸2009 |
1.35 EUR
|
| Aug. 27, 2009 | 1.3500 |
| ▸2008 |
1.30 EUR
|
| Aug. 29, 2008 | 1.3000 |
| ▸2007 |
1.20 EUR
|
| Sept. 13, 2007 | 1.2000 |
| ▸2006 |
1.10 EUR
|
| July 5, 2006 | 1.1000 |
| ▸2005 |
1.00 EUR
|
| July 5, 2005 | 1.0000 |
| ▸2004 |
1.62 EUR
|
| July 1, 2004 | 1.3500 |
| June 30, 2004 | 0.2700 |
| ▸2003 |
0.80 EUR
|
| June 5, 2003 | 0.8000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Equasens SA | Jul 03, 2026 | Paid | 1.4 EUR |
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 5, 2015 | 5:1 |
Community Discussion